[EN] DIHYDROQUINOLIZINONES AS ANTIVIRALS<br/>[FR] DIHYDROQUINOLIZINONES À UTILISER EN TANT QU'ANTIVIRAUX
申请人:GLAXOSMITHKLINE IP DEV LTD
公开号:WO2018154466A1
公开(公告)日:2018-08-30
Compounds, specifically hepatitis B virus and/or hepatitis D virus inhibitors, more specifically compounds that inhibit HBe antigen and HBs antigen in a subject, for the treatment of viral infections, and methods of preparing and using such compounds. Formula (I):
化合物,具体来说是乙型肝炎病毒和/或丙型肝炎病毒抑制剂,更具体地说是抑制受试者体内HBe抗原和HBs抗原的化合物,用于治疗病毒感染,并且涉及制备和使用这类化合物的方法。化学式(I):